Neuropathology of ALS: An overview

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Hirano, Asao ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL INCLUSION; CELL VACUOLE; GOLGI COMPLEX; HUMAN; LEWY BODY; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

EID: 0029838035     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.63s     Document Type: Review

References (44)

1. Hirano A. Cytopathology of amyotrophic lateral sclerosis: a personal perspective of recent developments. Neuropathology 1995;15:1-6.
2. Sasaki S, Maruyama S. Synapse loss of anterior horn neurons in amyotrophic lateral sclerosis. Acta Neuropathol 1994;88: 222-227.
3. Kawanami T, Ikemoto A, Llena JF, et al. Synaptophysin immunoreactivity pattern in the anterior horn cells in amyotrophic lateral sclerosis [abstract]. Can J Neurol Sci 1993;20:75.
4. Kato T, Hirano A, Donnenfeld H. A Golgi study of the large anterior horn cells of the lumbar cords in normal spinal cords and in amyotrophic lateral sclerosis. Acta Neuropathol 1987; 75:34-40.
5. Ikemoto A, Kawanami T, Llena JF, et al. Immunocytochemical studies on synaptophysin in the anterior horn of lower motor neuron disease. J Neuropathol Exp Neurol 1994;53: 196-201.
6. Matsumoto S, Goto S, Kusaka H, et al. Synaptic pathology of spinal anterior horn cells in amyotrophic lateral sclerosis: an immunohistochemical study. J Neurol Sci 1994;125:180-185.
7. Carpenter S. Proximal axonal enlargement in motor neuron disease. Neurology 1968;18:842-851.
8. Inoue K, Hirano A. Early pathological changes of amyotrophic lateral sclerosis. Autopsy findings of a case of 10 months duration. Neurol Med (Tokyo) 1979;11:448-455.
9. Gambetti P, Shecket G, Ghetti B, et al. Neurofibrillary changes in human brain: an immunocytochemical study with neurofilament antiserum. J Neuropathol Exp Neurol 1983;42: 69-79.
10. Matsumoto S, Mizusawa H, Yen S-H, et al. Immunocytochemical study of phosphorylated neurofilaments in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Med (Tokyo) 1989;30:370-377.
11. Mizusawa H, Matsumoto S, Yen S-H, et al. Focal accumulation of phosphorylated neurofilaments within anterior horn cells in familial amyotrophic lateral sclerosis. Acta Neuropathol 1989;79:37-43.
12. Sobue G, Hashizume Y, Yasuda T, et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol 1990;79:402-408.
13. Matsumoto S, Goto M, Kusaka H, et al. Ubiquitin-positive inclusion in anterior horn cells in subgroups of motor neuron disease: a comparative study of adult-onset amyotrophic lateral sclerosis, juvenile amyotrophic lateral sclerosis and Werdnig-Hoffmann disease. J Neurol Sci 1993;115:208-213.
14. Leigh PN, Anderton BH, Dodson A, et al. Ubiquitin deposit in anterior horn cells in motor neuron disease. Neurosci Lett 1988;93:197-203.
15. Lowe J, Lennox G, Jefferson D, et al. A filamentous inclusion body within anterior horn neurons in motor neuron disease defined by immunocytochemical localization of ubiquitin. Neurosci Lett 1988;94:203-210.
16. Mizusawa H, Nakamura H, Wakayama I, et al. Skein-like inclusions in the anterior horn cells in motor neuron disease. J Neurol Sci 1991;105:14-21.
17. Nakano I, Shibata T, Kuroda M, et al. Are skein-like inclusions (SLIs) in amyotrophic lateral sclerosis (ALS) [abstract] processed by lysosomes? Electron microscopic observation. Brain Pathol 1994;4:528.
18. Ito H, Hirano A. Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis. Acta Neuropathol 1994;87:425-429.
19. Leigh PN, Whitewell H, Garofalo O, et al. Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain 1991;114:775-588.
20. Suenaga T, Matsushima H, Nakamura S, et al. Ubiquitin immunoreactive inclusions in anterior horn cells and hypoglossal nucleus in a case with Joseph's disease. Acta Neuropathol 1993;85:341-344.
21. Mizutani T, Kakimi S, Yamaguchi H, et al. Ubiquitin-positive filamentous inclusions in amyotrophic lateral sclerosis (ALS) and other neurological diseases [abstract]. Brain Pathol 1994; 4:528.
22. Gonatas NK, Steiber A, Mourelatos Z, et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis. Am J Pathol 1992;140:731-737.
23. Mourelatos Z, Adler H, Hirano A, et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis revealed by organelle specific antibodies. Proc Natl Acad Sci USA 1990;87:4393-4395.
24. Mourelatos Z, Hirano A, Rosequist AC, et al. Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis (ALS). Clinical studies in differentiated neurons and in B, B-iminopropionitrile axonopathy. Am J Pathol 1994; 144:1288-1300.
25. Bunina TL. On intracellular inclusion in familial amyotrophic lateral sclerosis. Korsakov J Neuropathol Psychiat 1962;62: 1293-1299.
26. Hirano A. Pathology of amyotrophic lateral sclerosis. In: Gajdusek DC, Gibbs CJ Jr, Alpers M, eds. Slow, Latent and Temperate Virus Infection. Washington DC: NINDB Monograph No. 2, 1965:23-37.
27. Hart MN, Cancilla PA, Frommes S, et al. Anterior horn cell degeneration and Bunina-type inclusions associated with dementia. Acta Neuropathol 1977;38:225-228.
28. Okamoto K. Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 1993;13:193-199.
29. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis: a subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967;16:232-243.
30. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
31. Siddique T, Deng H-X, Juneja T, et al. The molecular basis of neurodegeneration in familial amyotrophic lateral sclerosis [abstract]. In: Nakano I, organizer. 11th TMIN International Symposium: Amyotrophic lateral sclerosis. Progress and Perspective in Basic Research and Clinical Application. Tokyo: Tokyo Metropolitan Institute for Neuroscience, 1995:58.
32. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-1775.
33. Dal Canto MC, Mourelatos Z, Gonatas NK, et al. Neuropathological changes in transgenic mice for mutant human Cu, Zn superoxide dysmutase (SOD) and in mice overexpressing wildtype human SOD [abstract]. In: Nakano I, organizer, 11th TMIN International Symposium: Amyotrophic Lateral Sclerosis. Progress and Perspective in Basic Research and Clinical Application. Tokyo: Tokyo Metropolitan Institute for Neuroscience, 1995:52.
34. Dal Canto M, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994;145:1271-1280.
35. Shibata N, Hirano A, Kobayashi M, et al. Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem Cytochem 1993;26:619-622.
36. Hirano A, Nakano I, Kurland LT, et al. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1984;43:471-480.
37. Pardo CA, Wong PC, Cleveland DW, et al. Gain of an adverse property by a mutant SOD-1 enzyme produce extensive motor neuron abnormalities in transgenic mice [abstract]. J Neuropathol Exp Neurol 1995;54:442.
38. Hirano A, Iwata M. Pathology of motor neurons with special reference to amyotrophic lateral sclerosis and related disease. In: Tsubaki T, Toyokura Y, eds. Amyotrophic Lateral Sclerosis. Tokyo: University of Tokyo Press, 1979:107-133.
39. Bruijin LI, Wong PC, Pardo CA, et al. Two familial ALS-linked SOD-1 mutants cause motor neuron disease in mice, but with markedly different pathologies [abstract]. In: Nakano I, organizer, 11th TMIN International Symposium. Amyotrophic Lateral Sclerosis. Progress and Perspective in Basic Research and Clinical Application. Tokyo: Tokyo Metropolitan Institute for Neuroscience, 1995:58.
40. Ripps M, Huntley GW, Hoff PR, et al. Transgenic mice expressing an altered murine superoxide dismutase gene provided an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995;92:686-693.
41. Takahashi H, Makifuchi T, Nakano R, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol 1994;88:185-188.
42. Kato S, Shimoda M, Morita T, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase (SOD-1) gene: siblings having one and a half-year and eleven-year clinical course [abstract]. J Neuropathol Exp Neurol 1995;5:443.
43. Takahashi H. Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene. Brain Nerve 1995;47:535-541.
44. Orrell RW, King AW, Hilton DA, et al. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intra familial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995;59:266-270.